With our unparalleled depth and breath of biotechnology experience, Triaj is uniquely positioned to provide a wide range of services to biotechnology and pharmaceutical companies, universities, governmental agencies, venture capitalists, investment banks, law firms and other institutions, including:

Special Project Advisory

Triaj has a global network of world-class scientific professionals, that allows Triaj to design, implement, assist in, and/or advise on biotechnology related projects of any size or type. Triaj is ready to meet the needs of biotechnology and pharmaceutical companies, universities, governmental agencies, venture capitalists, investment banks, law firms, and other businesses and institutions.

Engagement of Triaj for your biotechnology project will add value to your business at any stage of its lifecycle, from initial concept to multinational enterprise. Triaj brings rigorous independent review and oversight to any project, to help you identify and capitalize on new opportunities, manage initiatives, and maximize profit potential and economic value. Triaj is an invaluable resource in the development of ideas and the ultimate success of any project. We help you convert creative insight to action and operational excellence.

More »

Retained Advisory Services

Triaj's medium and long term retained advisory service contracts provide businesses throughout the biotechnology space with on-call access to the world's foremost biotechnology professionals. Triaj is ready to meet the needs of biotechnology and pharmaceutical companies, universities, governmental agencies, venture capitalists, investment banks, law firms, and other businesses and institutions.

A retained advisory service contract provides you with ongoing access to Triaj's resources. Triaj is there to answer all of your biotechnology related questions and to provide feedback on all biotechnology related issues. You are also provided with priority access to Triaj's resources for special project engagements.

As a retained advisor, Triaj undertakes a significant commitment to your success, whether you are a venture capitalist, investment banker, law firm, biotechnology or pharmaceutical company, governmental agency, or other business or institution. Let Triaj provide you with the scientific expertise critical to the success of your enterprise.

More »

Transaction and Project Screening

The decision to move forward with a biotechnology transaction or initiative involves a commitment of limited resources. Engage Triaj as your independent expert to provide early screening of your biotechnology transactions and initiatives before you commit your resources. Triaj helps you to choose transactions and projects that have the highest likelihood of future success.

Triaj's initial scientific screening is an impartial fact-driven process that increases your ability to identify and exploit new opportunities. Triaj's initial screening review services are tailored to meet the needs of the venture capital, investment banking and legal communities, as well as corporate development departments of biotechnology and pharmaceutical companies, and government agencies. We are equipped to screen any size or type of transaction, including venture capital investments, initial public offerings, mergers, acquisitions and dispositions, joint ventures and product development.

More »

Scientific Due Diligence Services

Once a decision is made to push forward a biotechnology transaction or initiative, Triaj can substantially reduce the risk profile of your investment and enhance returns with our in-depth due diligence and feasibility studies that bring an independent, expert review and quality assurance to your projects.

Triaj offers scientific due diligence and feasibility studies suitable for all sizes and types of transaction, including venture capital investments, mergers and acquisitions, IPOs and dispositions, joint ventures and alliances, product development projects and project funding. Our due diligence services are tailored to meet the exacting needs of the venture capital, investment banking and legal communities, and the corporate development departments of all biotech and pharmaceutical companies and governmental agencies.

No commercial transaction would be undertaken without the advice of legal, accounting and financial experts. Through Triaj, it is now possible to access independent, world-class scientific expertise.

More »